Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT04939324

Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer

Conditions: Lung Cancer, Exosomes, Non Small Cell Lung Cancer

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 30

Sponsor: University Hospital, Limoges

Location: CHU de Limoges Limoges Limoges

Summary

This is an observational prospective single-center study of 30 patients operated for early-staged non-small cell lung cancer. The main aim is the analysis of molecular profiling of exosome with a sample in tumor-draining vein in order to identify prognostic molecular characteristics associated with cancer recurrence after surgery.

Eligibility Criteria

Inclusion Criteria: \- Surgical non-small cell lung cancer with pure solid nodule or part-solid ground glass nodule on CT-scan Exclusion Criteria: * Pure ground glass nodule, * Neoadjuvant therapy, * Second cancer or cancer in the 5 years, * Pregnancy, * Patients \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04939324). StuddyBuddy aggregates publicly available trial information.